GR1000241B - Μεθοδος παρασκευης νεων παραγωγων της μορφολινης. - Google Patents

Μεθοδος παρασκευης νεων παραγωγων της μορφολινης.

Info

Publication number
GR1000241B
GR1000241B GR880100179A GR880100179A GR1000241B GR 1000241 B GR1000241 B GR 1000241B GR 880100179 A GR880100179 A GR 880100179A GR 880100179 A GR880100179 A GR 880100179A GR 1000241 B GR1000241 B GR 1000241B
Authority
GR
Greece
Prior art keywords
morpholine derivatives
preparing new
aralkyl
acyl
branched
Prior art date
Application number
GR880100179A
Other languages
English (en)
Other versions
GR880100179A (en
Inventor
Claude Guillonneau
Jean Lepagnol
Gilbert Regnier
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of GR880100179A publication Critical patent/GR880100179A/el
Publication of GR1000241B publication Critical patent/GR1000241B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Earth Drilling (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Control For Baths (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Τα νέα παράγωγα της μορφολίνης, τα οποία μπορούν να χρησιμοποιηθούν ως φάρμακα και ανταποκρίνονται εις τον τύπον ω
GR880100179A 1987-03-24 1988-03-23 Μεθοδος παρασκευης νεων παραγωγων της μορφολινης. GR1000241B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8704047A FR2612926B1 (fr) 1987-03-24 1987-03-24 Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
GR880100179A GR880100179A (en) 1989-01-31
GR1000241B true GR1000241B (el) 1992-05-12

Family

ID=9349348

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100179A GR1000241B (el) 1987-03-24 1988-03-23 Μεθοδος παρασκευης νεων παραγωγων της μορφολινης.

Country Status (17)

Country Link
US (1) US4782054A (el)
EP (1) EP0286495B1 (el)
JP (1) JPH0657709B2 (el)
AT (1) ATE89281T1 (el)
AU (1) AU600209B2 (el)
CA (1) CA1313870C (el)
DE (1) DE3880874T2 (el)
DK (1) DK171580B1 (el)
ES (1) ES2006390A6 (el)
FR (1) FR2612926B1 (el)
GR (1) GR1000241B (el)
HK (1) HK57297A (el)
IE (1) IE61882B1 (el)
NZ (1) NZ223984A (el)
OA (1) OA08822A (el)
PT (1) PT87061B (el)
ZA (1) ZA882107B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653999A1 (fr) * 1989-11-06 1991-05-10 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
KR100943555B1 (ko) * 2004-04-30 2010-02-22 워너-램버트 캄파니 엘엘씨 중추신경계 장애를 치료하기 위한 치환된 모르폴린 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la

Also Published As

Publication number Publication date
ATE89281T1 (de) 1993-05-15
PT87061B (pt) 1992-07-31
DK171580B1 (da) 1997-02-03
GR880100179A (en) 1989-01-31
OA08822A (fr) 1989-03-31
IE61882B1 (en) 1994-11-30
DK150088D0 (da) 1988-03-18
NZ223984A (en) 1990-05-28
AU1352088A (en) 1988-09-22
EP0286495A1 (fr) 1988-10-12
HK57297A (en) 1997-05-09
DE3880874T2 (de) 1993-12-23
PT87061A (pt) 1988-04-01
ZA882107B (en) 1989-06-28
FR2612926B1 (fr) 1989-06-09
IE880851L (en) 1988-09-24
JPS63255279A (ja) 1988-10-21
US4782054A (en) 1988-11-01
EP0286495B1 (fr) 1993-05-12
AU600209B2 (en) 1990-08-02
ES2006390A6 (es) 1989-04-16
CA1313870C (fr) 1993-02-23
DK150088A (da) 1988-09-25
FR2612926A1 (fr) 1988-09-30
DE3880874D1 (de) 1993-06-17
JPH0657709B2 (ja) 1994-08-03

Similar Documents

Publication Publication Date Title
PT80661A (en) Process for preparing substituted imidazopyridines
FI102756B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6H-bentsfuro[3a,3,3-ef][2]bentsatsepiinijohdannaisten valmistamiseksi
EP0244364A3 (en) Preparation of olefinic compounds
HU896737D0 (en) Process for the preparation of compounds useful as intermediates in the preparation of tetrazole derivatives reducing the pathologically high cholesterin level in blood
GR880100179A (en) Process of preparing new morpholine derivatives
PL300747A1 (en) Method of obtaining substantially pure clavulanic acid
BG60033A3 (en) METHOD FOR THE PREPARATION OF 4-(5,6,7,8-TETRAHYDROIMIDAZO-1,5-a/-PYRIDINE-5-YL) BENZONITRILE-HYDROCHLORIDE IN CRYSTAL SEMIHYDRATE FORM
HUT48464A (en) Process for producing pharmaceutical composition for treating hypertonia and cardiac failure
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
FR2653999B1 (el)
DE3477490D1 (en) Substituted pyridoû1,2-c¨imidazoû1,2-a¨benzimidazoles, process for their preparation, their use and pharmaceutical preparations containing them
PL246418A1 (en) Process for preparing n-/3-trifluoromethylphenyl/-n'-propargylpiperazine
HUT46909A (en) Process for production of substituated quinoxanileimidasoline-2,4-dions and medical preparatives containing such compositions
DE3466877D1 (en) Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
ZA88640B (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,medicaments containing same,and the use thereof,and some intermediates formed in the preparation of the compounds mentioned
DE3377415D1 (en) Novel phenylpiperazine derivatives, process for preparing them and therapeutic compositions containing them
AU2046888A (en) Process for the preparation of n6-benzyloxycarbonyl-2,6- diaminopimelamic acid in the l, l or d, d or racemic forms

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees